These factors incorporated tumor differentiation (HR = 1.544; 95% CI = 1.072-2.226), preoperative SII (HR = 3.918; 95% CI = 1.586-9.683), postoperative PIVKA-II level (HR = 4.954; 95% CI = 2.582-9.505), tumor number (HR = 2.7808; 95% CI = 1.577-4.903), and postoperative AFP levels (25–400 ng/mL vs. ≤25 ng/mL: HR = 2.591; 95% CI = 1.153-5.823; ≥400 ng/mL vs. ≤25 ng/mL: HR = 44.793; 95% CI = 13.145-152.633). This evidence concerns the gene AFP and neoplasm.